An Atypical Femoral Fracture in a Patient on Long-term Alendronate Therapy
Yükleniyor...
Dosyalar
Tarih
2014
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Informa Healthcare
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Background: Biphosphonates, especially alendronate, are used extensively and successfully for the treatment of osteoporosis. However, there are numerous recent studies that indicate low-energy subtrochanteric femoral fractures can be associated with long-term alendronate therapy. Findings: We present a 76-year-old female patient who has taken 70 mg alendronate per week for 7 years, and who presented with pain in the left thigh. Conclusions: The patient was diagnosed as atypical femoral fracture resulting from long-term alendronate use. The diagnosis and the treatment will be discussed with a review of the literature.
Açıklama
WOS: 000340826100016
Anahtar Kelimeler
Alendronate, atypical femoral fracture, hip fractures, osteoporosis, osteoporotic fractures
Kaynak
Journal Of Musculoskeletal Pain
WoS Q Değeri
Q4
Scopus Q Değeri
N/A
Cilt
22
Sayı
3
